Loading...
Triple Reuptake Inhibitors: A Premise and Promise
On the horizon there is a new class of psychoactive medications which work by inhibiting the neuronal reuptake of serotonin, norepinephrine, and dopamine. There are multiple potential indications for these drugs. Research suggests that they may have a role in treating depressive disorders, and it is...
Saved in:
Main Authors: | , , |
---|---|
Format: | Artigo |
Language: | Inglês |
Published: |
Korean Neuropsychiatric Association
2008
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2796030/ https://ncbi.nlm.nih.gov/pubmed/20046357 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4306/pi.2008.5.3.142 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|